Literature DB >> 9765283

SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors.

B A Binstadt1, D D Billadeau, D Jevremović, B L Williams, N Fang, T Yi, G A Koretzky, R T Abraham, P J Leibson.   

Abstract

Activation of immune system cells via antigen-, Fc-, or natural killer cell-triggering-receptor stimulation is aborted by co-engagement of inhibitory receptors. Negative signaling by killer cell inhibitory receptors and related receptors depends on the Src homology 2 (SH2)-containing protein tyrosine phosphatase SHP-1. Using a combination of direct binding and functional assays, we demonstrated that the SH2 domain-containing leukocyte protein 76 (SLP-76) is a specific target for dephosphorylation by SHP-1 in T cells and natural killer cells. Furthermore, we showed that tyrosine-phosphorylated SLP-76 is required for optimal activation of cytotoxic lymphocytes, suggesting that the targeted dephosphorylation of SLP-76 by SHP-1 is an important mechanism for the negative regulation of immune cell activation by inhibitory receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765283     DOI: 10.1074/jbc.273.42.27518

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  ITAMs versus ITIMs: striking a balance during cell regulation.

Authors:  Daniel D Billadeau; Paul J Leibson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity.

Authors:  Christopher C Stebbins; Carsten Watzl; Daniel D Billadeau; Paul J Leibson; Deborah N Burshtyn; Eric O Long
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 3.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

Review 4.  The conundrum of inhibitory signaling by ITAM-containing immunoreceptors: potential molecular mechanisms.

Authors:  Paul M Waterman; John C Cambier
Journal:  FEBS Lett       Date:  2010-09-28       Impact factor: 4.124

Review 5.  Shp1 function in myeloid cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  J Leukoc Biol       Date:  2017-06-12       Impact factor: 4.962

6.  Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.

Authors:  Suman Kundu; Keke Fan; Mingli Cao; Daniel J Lindner; Zhizhaung Joe Zhao; Ernest Borden; Taolin Yi
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

Review 7.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  Dynamin 2 regulates granule exocytosis during NK cell-mediated cytotoxicity.

Authors:  Laura N Arneson; Colin M Segovis; Timothy S Gomez; Renee A Schoon; Christopher J Dick; Zhenkun Lou; Daniel D Billadeau; Paul J Leibson
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 9.  A new look at T cell receptor signaling to nuclear factor-κB.

Authors:  Suman Paul; Brian C Schaefer
Journal:  Trends Immunol       Date:  2013-03-07       Impact factor: 16.687

10.  PI3K links NKG2D signaling to a CrkL pathway involved in natural killer cell adhesion, polarity, and granule secretion.

Authors:  Colin M Segovis; Renee A Schoon; Christopher J Dick; Lucas P Nacusi; Paul J Leibson; Daniel D Billadeau
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.